Related Experiment Video
Updated: Aug 10, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Leptin and preeclampsia
1Maternal and Fetal Research Unit, Guy's Kings and St. Thomas' School of Medicine, King's College, London, United Kingdom.
Insights
Preeclampsia involves higher maternal leptin levels before symptoms appear. The placenta may cause this increase, potentially affecting fetal growth or blood pressure.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Perinatal Medicine
Background:
- Preeclampsia is a common pregnancy complication.
- Elevated maternal serum leptin concentrations are observed before preeclampsia onset.
- Leptin's role in preeclampsia pathogenesis remains unclear.
Purpose of the Study:
- To review potential sources of increased maternal leptin during pregnancy.
- To explore the possible consequences of elevated leptin in preeclampsia.
- To highlight areas for future research on leptin and preeclampsia.
Main Methods:
- Literature review of studies on leptin and preeclampsia.
- Analysis of potential stimuli for leptin production (e.g., placental hypoxia, inflammation).
- Discussion of proposed physiological effects of increased leptin.
Main Results:
- The placenta is a likely contributor to elevated maternal leptin.
- Placental hypoxia and inflammatory mediators may stimulate leptin release.
- Potential consequences include effects on fetal growth and maternal blood pressure via sympathetic activity.
Conclusions:
- The rise in maternal leptin may originate from the placenta, influenced by hypoxia and inflammation.
- Increased leptin could have dual effects, potentially benefiting fetal growth or increasing blood pressure.
- Further research is crucial to ascertain if leptin is a causal factor or a bystander in preeclampsia.
Abstract:
Preeclampsia, a common complications of pregnancy, is associated with an increase in the concentration of leptin in the maternal blood, which precedes the clinical onset of the disease. This review addresses the potential sources of leptin and considers the possible consequences, although at present these are entirely conjectural. The placenta is likely to contribute to the rise in leptin, and placental hypoxia and inflammatory mediators may be important stimuli. The possible protective and damaging sequelae of an increase in the maternal leptin concentrations may range from beneficial stimulation of fetal growth to an increase in blood pressure through stimulation of sympathetic activity. Further research is needed to determine if the rise in leptin plays a role in preeclampsia or whether it is a secondary and unrelated bystander.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
05:31Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Related Concept Videos
Cell Specific Gene Expression
Teratogenicity
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Dipeptidyl Peptidase 4 Inhibitors
Diabetic Retinopathy